4/A: Akoya Biosciences CEO Brian McKelligon Executes Option and Sells Shares Under 10b5-1 Plan
SEC Form 4/A (Amendment to Statement of Changes in Beneficial Ownership)
Akoya Biosciences CEO Brian McKelligon exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On March 13, 2024, Brian McKelligon, the President and CEO of Akoya Biosciences, Inc., exercised options to purchase 7,500 shares of common stock at a price of $0.303 per share.
- Simultaneously, McKelligon sold 7,500 shares of Akoya Biosciences common stock at a weighted average price of $4.939 per share, with individual sales prices ranging from $4.81 to $5.08.
- These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on August 16, 2023.
- Following these transactions, McKelligon directly owns 231,868 shares of Akoya Biosciences common stock.
- McKelligon also holds options to purchase 298,129 shares of common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by an insider. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
This filing is a routine disclosure of insider trading activity. It is common for executives to use Rule 10b5-1 plans to sell shares over time to avoid accusations of trading on inside information.
Stakeholder Impact
- The sale of shares by the CEO could be perceived negatively by some investors, although it is part of a pre-planned strategy.
- The exercise of options dilutes existing shareholders to a small degree.
Key Dates
| Date | Description |
|---|---|
| 08/16/2023 | Date of adoption of Rule 10b5-1 trading plan |
| 03/13/2024 | Date of transaction (exercise of options and sale of shares) |
| 03/14/2024 | Date of original filing |
| 03/22/2024 | Date of Form 4/A filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.